Figures & data
Table 1. Compound (1). 1H-NMR (100 MHz, CDCl3) and 13C-NMR (600 MHz, CDCl3) chemical shift assignments of ezetimibe (1) (3R, 4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl) azetidin-2-one (1).
Table 2. Compound (2). 1H-NMR (100 MHz, CDCl3) and 13C-NMR (600 MHz, CDCl3) chemical shift assignments of (3R,4S)-1-(4-fluorophenyl)-3-((E)-3-(4-fluorophenyl) allyl)-4-(4-hydroxyphenyl) azetidin-2-one (2).
Table 3. Compound (3). H-NMR (100 MHz, CDCl3) and 13C-NMR (600 MHz, CDCl3) chemical shift assignments of (3R,4S)-1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-oxopropyl)-4-(4-hydroxyphenyl) azetidin-2-one (3).
Table 4. Compound (4). 1H-NMR (100 MHz, CDCl3) and 13C-NMR (600 MHz, CDCl3) chemical shift assignments of (3R,4S) 1-(4-fluorophenyl)-3-(3-(4-fluorophenyl) propyl)-4-(4-hydroxyphenyl) azetidin-2-one (4).
Table 5. Compound (5). 1H-NMR (100 MHz, CDCl3) and 13C-NMR (600 MHz, CDCl3) chemical shift assignments of (2R,5S)-N, 5-bis (4-fluorophenyl)-5-hydroxy-2-(4-hydroxybenzyl) pentanamide (5).